TherapeuticsMD (TXMD) Short-term Investments (2022)
TherapeuticsMD's (TXMD) quarterly Short-term Investments came in at $11.2 million in Q4 2022, little changed on a QoQ basis from $11.2 million in Q3 2022.
TherapeuticsMD (TXMD) Short-term Investments (2022) Analysis & Trends
TherapeuticsMD (TXMD) has 1 years of Short-term Investments data on file, last reported at $11.2 million in Q4 2022.
- Quarterly Short-term Investments changed N/A year-over-year to $11.2 million in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $11.2 million (changed N/A YoY) and the FY2022 annual result came in at $11.2 million, changed N/A from the prior year.
- Short-term Investments held at $11.2 million in Q4 2022, from $11.2 million in the prior quarter.
- In the past five years, Short-term Investments ranged from a high of $11.2 million in Q2 2022 to a low of $11.2 million in Q2 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | TherapeuticsMD | 23.78 Mn | 14.60 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 11.25 Mn |
| Sep 30, 2022 | 11.25 Mn |
| Jun 30, 2022 | 11.25 Mn |